Novozymes As Stock Price on August 27, 2024
NVZMY Stock | USD 58.24 0.78 1.32% |
If you're considering investing in Novozymes Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Novozymes stands at 58.24, as last reported on the 4th of December, with the highest price reaching 58.54 and the lowest price hitting 58.24 during the day. Novozymes AS has Sharpe Ratio of -0.15, which conveys that the firm had a -0.15% return per unit of risk over the last 3 months. Novozymes exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novozymes' Mean Deviation of 1.04, risk adjusted performance of (0.13), and Standard Deviation of 1.45 to check out the risk estimate we provide.
Novozymes Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Novozymes |
Sharpe Ratio = -0.15
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NVZMY |
Estimated Market Risk
1.46 actual daily | 13 87% of assets are more volatile |
Expected Return
-0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novozymes is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novozymes by adding Novozymes to a well-diversified portfolio.
Related Headline
Albemarle Corp Headline on 27th of August 2024
Disposition of 2824 shares by Mark Mummert of Albemarle Corp... by Mark Mummert
Filed transaction by Albemarle Corp Officer Svp, Capital Projects. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Novozymes Valuation on August 27, 2024
It is possible to determine the worth of Novozymes on a given historical date. On August 27, 2024 Novozymes was worth 67.81 at the beginning of the trading date compared to the closed value of 67.81. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novozymes pink sheet. Still, in general, we apply an absolute valuation method to find Novozymes' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novozymes where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novozymes' related companies.
Open | High | Low | Close | Volume | |
67.22 | 67.22 | 67.22 | 67.22 | 14,310 | |
08/27/2024 | 67.81 | 67.81 | 67.81 | 67.81 | 19,506 |
68.66 | 68.66 | 68.66 | 68.66 | 4,263 |
Backtest Novozymes | | | Novozymes History | | | Novozymes Valuation | Previous | Next |
Novozymes Trading Date Momentum on August 27, 2024
On August 28 2024 Novozymes AS was traded for 68.66 at the closing time. The highest daily price throughout the period was 68.66 and the lowest price was 68.66 . The daily volume was 4.3 K. The net trading volume on 08/28/2024 added to the next day price jump. The trading delta at closing time to closing price of the next trading day was 1.25% . The trading delta at closing time to current closing price is 0.49% . |
Novozymes AS Fundamentals Correlations and Trends
By evaluating Novozymes' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novozymes' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novozymes financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Novozymes Pink Sheet history
Novozymes investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novozymes is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novozymes AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novozymes stock prices may prove useful in developing a viable investing in Novozymes
Novozymes AS produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark. Novozymes Unspn is traded on OTC Exchange in the United States.
Novozymes Pink Sheet Technical Analysis
Novozymes technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Novozymes Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Novozymes AS cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Novozymes December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Novozymes pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novozymes shares will generate the highest return on investment. By undertsting and applying Novozymes pink sheet market strength indicators, traders can identify Novozymes AS entry and exit signals to maximize returns
Novozymes Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novozymes' price direction in advance. Along with the technical and fundamental analysis of Novozymes Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novozymes to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.13) | |||
Jensen Alpha | (0.25) | |||
Total Risk Alpha | (0.46) | |||
Treynor Ratio | 1.97 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Novozymes Pink Sheet Analysis
When running Novozymes' price analysis, check to measure Novozymes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novozymes is operating at the current time. Most of Novozymes' value examination focuses on studying past and present price action to predict the probability of Novozymes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novozymes' price. Additionally, you may evaluate how the addition of Novozymes to your portfolios can decrease your overall portfolio volatility.